- Home
- UNM vs BMRN Comparison
UNM vs BMRN Comparison
Compare UNM & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNM
- BMRN
- Stock Information
- Founded
- UNM 1848
- BMRN 1996
- Country
- UNM United States
- BMRN United States
- Employees
- UNM N/A
- BMRN N/A
- Industry
- UNM Accident &Health Insurance
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- UNM Finance
- BMRN Health Care
- Exchange
- UNM Nasdaq
- BMRN Nasdaq
- Market Cap
- UNM 14.4B
- BMRN 13.7B
- IPO Year
- UNM 1986
- BMRN 1999
- Fundamental
- Price
- UNM $82.06
- BMRN $67.94
- Analyst Decision
- UNM Buy
- BMRN Buy
- Analyst Count
- UNM 13
- BMRN 22
- Target Price
- UNM $85.23
- BMRN $94.00
- AVG Volume (30 Days)
- UNM 1.9M
- BMRN 1.4M
- Earning Date
- UNM 04-29-2025
- BMRN 04-23-2025
- Dividend Yield
- UNM 2.05%
- BMRN N/A
- EPS Growth
- UNM 45.54
- BMRN 153.71
- EPS
- UNM 9.46
- BMRN 2.21
- Revenue
- UNM $12,887,300,000.00
- BMRN $2,853,915,000.00
- Revenue This Year
- UNM $5.25
- BMRN $12.23
- Revenue Next Year
- UNM $4.50
- BMRN $9.90
- P/E Ratio
- UNM $8.67
- BMRN $30.82
- Revenue Growth
- UNM 4.05
- BMRN 17.97
- 52 Week Low
- UNM $48.38
- BMRN $60.63
- 52 Week High
- UNM $84.48
- BMRN $94.85
- Technical
- Relative Strength Index (RSI)
- UNM 57.34
- BMRN 40.59
- Support Level
- UNM $79.08
- BMRN $69.60
- Resistance Level
- UNM $84.48
- BMRN $73.18
- Average True Range (ATR)
- UNM 1.88
- BMRN 1.75
- MACD
- UNM -0.08
- BMRN -0.46
- Stochastic Oscillator
- UNM 68.28
- BMRN 1.69
About UNM Unum Group
Unum Group is a provider of group and individual income protection insurance products in the United States, the United Kingdom, Poland, and other countries. It is the domestic disability insurer, with the majority of premiums generated from employer plans. The company also offers a complementary portfolio of other insurance products, including long-term care insurance, life insurance, and employer- and employee-paid group benefits. It has the following operating business segments: Unum USA, Unum International, Closed Block, Colonial Life, and Corporate. The majority of the revenue is earned from the Unum USA segment. The firm markets its products through brokers.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.